
Texas: According to a new study using technology created by a researcher at UTHealth Houston, the presence of a misfolded alpha-synuclein protein can be used to assess whether people have Parkinson's disease. This biomarker may open the door to the creation of improved diagnostic equipment and fresh disease-treating approaches.